Reassessing the OX40 / OX40L axis in atopic dermatitis after the termination of Rocatinlimab's clinical development program

Journal of the European Academy of Dermatology and Venereology · Published 2026-07-31 · DOI 10.1111/jdv.70460

Free full text

Authors (1)

Thomas Bieber

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year
2026

Citation

Bieber, T. (2026). Reassessing the OX40 / OX40L axis in atopic dermatitis after the termination of Rocatinlimab's clinical development program. Journal of the European Academy of Dermatology and Venereology. https://doi.org/10.1111/jdv.70460

Related articles